Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration. 1984

A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold

Sensitivity to insulin in vivo was studied in six Type 1 diabetic patients without residual insulin secretion and without clinical insulin resistance, and in eight non-diabetic subjects, using the euglycaemic insulin clamp technique. Insulin was infused for four periods of 2 h sequentially at 0.5, 1.0, 2.0 and 5.0 mU X kg-1 X min-1; for each insulin infusion period the steady-state plasma free insulin levels were comparable in the diabetic and non-diabetic subjects. The mean +/- SEM plasma glucose concentration was 4.9 +/- 0.03 mmol/l in the diabetic subjects (coefficient of variation of plasma glucose values: 5.7 +/- 0.7%) and 4.6 +/- 0.01 mmol/l in the control subjects (coefficient of variation: 5.1 +/- 0.6%). Insulin-mediated glucose disposal was lower in the diabetic than in the non-diabetic subjects at the two lower insulin infusion rates (mean +/- SEM = 2.03 +/- 0.27 versus 4.8 +/- 0.64 mg X kg-1 X min-1 at the first insulin infusion rate, p less than 0.01, and 5.59 +/- 0.59 versus 8.36 +/- 0.61 mg X kg-1 X min-1 at the second insulin infusion rate, p less than 0.01). However, insulin-induced glucose uptake did not differ significantly between the two groups at the third and fourth rates of insulin infusion. These results show that impaired insulin sensitivity in Type 1 diabetes is dependent on insulin concentration.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
May 1984, Clinical endocrinology,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
January 1995, The Netherlands journal of medicine,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
January 2002, Diabetes/metabolism research and reviews,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
January 1985, Advances in experimental medicine and biology,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
September 1990, Diabetes research (Edinburgh, Scotland),
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
August 1988, Diabetologia,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
September 2008, Diabetic medicine : a journal of the British Diabetic Association,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
December 2015, Metabolism: clinical and experimental,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
October 1987, Diabetologia,
A Pernet, and E R Trimble, and F Kuntschen, and P Damoiseaux, and J P Assal, and C Hahn, and A E Renold
October 1984, Recenti progressi in medicina,
Copied contents to your clipboard!